The knownwell team is at ObesityWeek® listening live to the White House’s announcement on expanded access to GLP-1 medications! After a year marked by access restrictions, it’s encouraging to see momentum building toward broader coverage and more sustainable treatment models as we move into 2026. Recognition by the White House marks an important narrative shift, one we live by: obesity is a chronic condition, not a lifestyle choice, and it deserves appropriate medication access and coverage. We hope this is the first step in making anti-obesity medications more affordable. This is a wonderful step towards broad affordability that we celebrate as patients and clinicians! 🎉 🎉 Read more: https://lnkd.in/gg7UQmMv #ObesityWeek #ObesityCare
